glp-1 reactive hypoglycemia GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous production and L-cell differentiation | Diabetology & Metabolic Syndrome Frontiers | The Role of

Results The gut microbiota affects locomotion via GLP-1 signaling Animals displayed altered locomotion when their gut microbiome was depleted 13,14,15,16 , suggesting that locomotion is associated with the status of bacterial colonization, specific bacteria, and their metabolites 13,14,15,16

Metformin targets intestinal immune system signaling pathways in a high-fat diet-induced mouse model of obesity and insulin resistance

Alomar M, Tawfiq AM, Hassan N, et al

Which is better: semaglutide or tirzepatide

Chuback explains: What trans fats actually are Why they became so common in processed foods How they affect the arteries and cardiovascular system Why food labels can sometimes be misleading What ingredients people should pay attention to How small daily choices impact long-term heart health This is why awareness matters

Importantly, this is the first biologic to show a truly meaningful level of clinical effect in patients, which could expand the number of patients we can treat with this immune disorder," said Jonathan Silverberg, Dermatologist at The George Washington University School of Medicine and Health Sciences, in the press release